MPJE Drug Recalls, Adverse Event Reporting, and Risk Management 2 — Questions and Answers
Question 1: MedWatch, the FDA Safety Information and Adverse Event Reporting Program, covers which category of products?
- Only prescription drugs
- Only OTC medications
- Human medical products including drugs, biologics, and medical devices (Correct answer)
- Only biological products
Correct answer: Human medical products including drugs, biologics, and medical devices
MedWatch covers all human medical products regulated by the FDA, including prescription drugs, OTC medications, biologics, and medical devices.
Question 2: Drug manufacturers are required to submit expedited adverse event reports to the FDA within how many calendar days for serious and unexpected adverse drug reactions?
- 7 calendar days
- 15 calendar days (Correct answer)
- 30 calendar days
- 45 calendar days
Correct answer: 15 calendar days
Under 21 CFR 314.81, manufacturers must submit expedited safety reports to the FDA within 15 calendar days for serious and unexpected adverse drug reactions.
Question 3: Which program is specifically designed to monitor adverse events related to vaccines in the United States?
- MedWatch
- VAERS (Vaccine Adverse Event Reporting System) (Correct answer)
- FAERS
- REMS
Correct answer: VAERS (Vaccine Adverse Event Reporting System)
VAERS (Vaccine Adverse Event Reporting System) is a national program co-managed by CDC and FDA specifically for monitoring vaccine safety.
Question 4: The FDA Adverse Event Reporting System (FAERS) database is primarily used for which post-market purpose?
- Approving new drug applications
- Post-marketing safety surveillance and pharmacovigilance (Correct answer)
- Setting drug reimbursement rates
- Issuing and renewing pharmacy licenses
Correct answer: Post-marketing safety surveillance and pharmacovigilance
FAERS is used for post-marketing safety surveillance, helping the FDA identify new safety signals and monitor known risks for approved drugs and therapeutic biologics.
Question 5: Which of the following constitutes a 'serious' adverse event under FDA adverse event reporting definitions?
- Any side effect requiring a dose adjustment
- An event resulting in death, hospitalization, persistent disability, or congenital anomaly (Correct answer)
- Any event reported by a patient regardless of severity
- Any event requiring an OTC medication for treatment
Correct answer: An event resulting in death, hospitalization, persistent disability, or congenital anomaly
Under FDA definitions, a serious adverse event includes outcomes such as death, inpatient hospitalization, persistent or significant disability, congenital anomaly, or other medically important conditions.
Question 6: Under federal law, who bears primary responsibility for initiating a drug recall when a product is found to be adulterated or misbranded?
- The FDA always initiates all recalls by court order
- The manufacturer or distributor bears primary responsibility for initiating the recall (Correct answer)
- State boards of pharmacy are responsible for all recall actions
- The DEA initiates all drug product recalls
Correct answer: The manufacturer or distributor bears primary responsibility for initiating the recall
Most drug recalls are voluntary and initiated by the manufacturer or distributor, though the FDA can request a recall and mandate one if a company does not act voluntarily.
MPJE Drug Recalls, Adverse Event Reporting, and Risk Management 2
MedWatch, the FDA Safety Information and Adverse Event Reporting Program, covers which category of products?